Picasso Kapital
Picasso Kapital AS is a strategic investment firm based in Harstad, Norway, focused on long-term investments. Historically, the firm specialized in the healthcare sector, actively seeking opportunities to enhance its portfolio. Through its investment strategies, Picasso Kapital aimed to generate sustainable growth and value over time.
1 past transactions
Lytix Biopharma
Venture Round in 2009
Lytix Biopharma ASA is a clinical-stage biotechnology company based in Oslo, Norway, with an additional office in Tromsø. Founded in 2003, the company specializes in developing innovative cancer immunotherapies designed to activate the patient's immune system against tumors. Lytix Biopharma's lead product, LTX-315, is an oncolytic peptide that modifies the tumor microenvironment by releasing potent immune stimulants and tumor antigens. The company is also advancing other products in its pipeline, including LTX-401. In addition to its therapeutic development, Lytix Biopharma provides research and development services in the field of anti-microbials and cancer therapeutics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.